EKF Diagnostics cancels 5.8 million treasury shares

Published 25/06/2025, 12:10
 EKF Diagnostics cancels 5.8 million treasury shares

LONDON - EKF Diagnostics Holdings plc (AIM:EKF), a global diagnostics business, announced Wednesday it has cancelled 5,836,774 ordinary shares previously held in treasury, effective June 24, 2025.

The cancellation includes 4,636,774 shares from a completed share buyback program announced on May 13, plus an additional 1,200,000 treasury shares.

Following the cancellation, EKF’s total issued share capital consists of 449,093,790 ordinary shares with one voting right per share. The company no longer holds any shares in treasury.

EKF also confirmed it continues to pursue additional on-market purchases of ordinary shares worth up to approximately £1 million, as authorized at its annual general meeting on May 20. Any repurchased shares will be held in treasury.

The company stated that shareholders may use the 449,093,790 figure as the denominator for calculations to determine if they need to notify interest changes under the FCA’s Disclosure and Transparency Rules.

EKF Diagnostics, which operates manufacturing sites across the US and Germany with headquarters near Cardiff, sells into over 120 countries worldwide. The information was provided in a company press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.